ITEM 1. Security and Issuer.
This Amendment No. 4 to Schedule 13D (this “Amendment
No. 4”) is being filed by Exor N.V., a Dutch public limited
liability company (naamloze vennootschap) (“Exor”), to amend
the Schedule 13D filed by Exor S.p.A., a società per azioni
organized under the laws of the Republic of Italy, as predecessor
in interest to Exor, with the Securities and Exchange Commission
(“SEC”) on October 22, 2014 (the “Original 13D”) as amended by
Amendment No. 1 to Schedule 13D filed with the SEC on
December 16, 2014 (“Amendment No. 1”), Amendment
No. 2 to Schedule 13D filed with the SEC on December 15,
2016 (“Amendment No. 2”) and Amendment No. 3 to Schedule
13D filed with the SEC on February 3, 2021 (“Amendment
No. 3”, and together with the Original Schedule 13D, Amendment
No. 1, Amendment No. 2 and this Amendment No. 4
“Schedule 13D”), and relates to the common shares, par value €0.01
per share, of Stellantis N.V., a Dutch public limited liability
company (naamloze vennootschap) (the “Issuer”), the
principal executive office of which is located at Singaporestraat
92, 1175 RA, Lijnden, The Netherlands. Each capitalized term used
and not defined herein shall have the meaning assigned to such term
in the Original 13D, as amended. Except as otherwise provided
herein, each Item of the Original 13D, as amended, remains
This Amendment No. 4 is being filed to amend Item 2, Item 5
and Item 6 as follows.
ITEM 2. Identity and Background.
Item 2 is hereby amended and partially restated by replacing the
first paragraph with the following:
(a)-(c) This Schedule 13D is filed by Exor N.V. (“Exor” or the
“Reporting Person”), a Dutch public limited liability company
(naamloze vennootschap) and successor to Exor S.p.A. by
virtue of a cross-border merger of Exor S.p.A. with and into Exor.
Exor is an investment company, which focuses its business on
long-term investments in global companies in diversified sectors,
mainly in Europe and the United States. The address of Exor’s
principal business and principal office is Gustav Mahlerplein 25,
1082 MS, Amsterdam, The Netherlands. The name, business address,
present principal occupation or employment (and the name, principal
business and address of any corporation or other organization in
which such employment is conducted) and citizenship of each
executive officer and director of Exor, each person controlling
Exor and each executive officer and director of any corporation or
other person in control of Exor are set forth in Schedule A
ITEM 5. Interest in Securities of the Issuer.
Item 5 is hereby amended and partially restated by replacing
paragraphs (a) through (c) with the following:
(a) Rows (11) and (13) of the cover pages to this Amendment
No. 4 are incorporated by reference herein.
(b) Rows (7) through (10) of the cover pages to this Amendment
No. 4 are hereby incorporated by reference herein.
Furthermore, the following persons listed in Item 2(a)(c) above
beneficially own common shares of the Issuer: